Follow
Sadaf Ghaem-Maghami
Sadaf Ghaem-Maghami
Verified email at imperial.ac.uk
Title
Cited by
Cited by
Year
Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer
SS Myatt, J Wang, LJ Monteiro, M Christian, KK Ho, L Fusi, RE Dina, ...
Cancer research 70 (1), 367-377, 2010
4172010
Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis
S Ghaem-Maghami, S Sagi, G Majeed, WP Soutter
The lancet oncology 8 (11), 985-993, 2007
3582007
Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis
M Arbyn, CWE Redman, F Verdoodt, M Kyrgiou, M Tzafetas, ...
The Lancet Oncology 18 (12), 1665-1679, 2017
3052017
Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis
J Kaijser, A Sayasneh, K Van Hoorde, S Ghaem-Maghami, T Bourne, ...
Human reproduction update 20 (3), 449-462, 2014
2612014
Indications for caesarean section
Z Penn, S Ghaem-Maghami
Best practice & research Clinical obstetrics & gynaecology 15 (1), 1-15, 2001
2322001
Standardized approach for imaging and measuring Cesarean section scars using ultrasonography
O Naji, Y Abdallah, AJ Bij De Vaate, A Smith, A Pexsters, C Stalder, ...
Ultrasound in obstetrics & gynecology 39 (3), 252-259, 2012
2232012
Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20.
A Du Bois, I Vergote, G Ferron, A Reuss, W Meier, S Greggi, PT Jensen, ...
Journal of Clinical Oncology 35 (15_suppl), 5501-5501, 2017
2172017
Endometrial cancer
S Saso, J Chatterjee, E Georgiou, AM Ditri, JR Smith, S Ghaem-Maghami
Bmj 343, 2011
1982011
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome
EJ Crosbie, NAJ Ryan, MJ Arends, T Bosse, J Burn, JM Cornes, ...
Genetics in Medicine 21 (10), 2390-2400, 2019
1922019
Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III/ENGOT-ov20.
A Du Bois, J Sehouli, I Vergote, G Ferron, A Reuss, W Meier, S Greggi, ...
Journal of Clinical Oncology 38 (15_suppl), 6000-6000, 2020
1722020
Randomized trial of cytoreductive surgery for relapsed ovarian cancer
P Harter, J Sehouli, I Vergote, G Ferron, A Reuss, W Meier, S Greggi, ...
New England Journal of Medicine 385 (23), 2123-2131, 2021
1692021
The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer
TG Hopkins, M Mura, HA Al-Ashtal, RM Lahr, N Abd-Latip, K Sweeney, ...
Nucleic acids research 44 (3), 1227-1246, 2016
1532016
Ovarian cancer immunotherapy using PD‐L1 siRNA targeted delivery from folic acid‐functionalized polyethylenimine: strategies to enhance T cell killing
PY Teo, C Yang, LM Whilding, AC Parente‐Pereira, J Maher, AJT George, ...
Advanced healthcare materials 4 (8), 1180-1189, 2015
1512015
Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer
CJ Maine, NHA Aziz, J Chatterjee, C Hayford, N Brewig, L Whilding, ...
Cancer immunology, immunotherapy 63, 215-224, 2014
1512014
Human uterine transplantation: a review of outcomes from the first 45 cases
BP Jones, S Saso, T Bracewell‐Milnes, MY Thum, J Nicopoullos, ...
BJOG: An International Journal of Obstetrics & Gynaecology 126 (11), 1310-1319, 2019
1482019
The surgical intelligent knife distinguishes normal, borderline and malignant gynaecological tissues using rapid evaporative ionisation mass spectrometry (REIMS)
DL Phelps, J Balog, LF Gildea, Z Bodai, A Savage, MA El-Bahrawy, ...
British journal of cancer 118 (10), 1349-1358, 2018
1442018
Multicentre external validation of IOTA prediction models and RMI by operators with varied training
A Sayasneh, L Wynants, J Preisler, J Kaijser, S Johnson, C Stalder, ...
British journal of cancer 108 (12), 2448-2454, 2013
1412013
Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity?
SJC Van der Stegen, DM Davies, S Wilkie, J Foster, JK Sosabowski, ...
The Journal of Immunology 191 (9), 4589-4598, 2013
1282013
Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells
T Goto, M Takano, A Albergaria, J Briese, KM Pomeranz, B Cloke, L Fusi, ...
Oncogene 27 (1), 9-19, 2008
1192008
Hydrophobic modification of low molecular weight polyethylenimine for improved gene transfection
PY Teo, C Yang, JL Hedrick, AC Engler, DJ Coady, S Ghaem-Maghami, ...
Biomaterials 34 (32), 7971-7979, 2013
1152013
The system can't perform the operation now. Try again later.
Articles 1–20